understanding your genetic profile can support conversations with your provider about which peptide therapies align with your physiology
In published preclinical research, BPC-157 has been administered at doses ranging from 6 to 50 micrograms per kilogram body weight in animal models, with most tissue-repair and gastric-protection protocols using 10 to 20 mcg/kg once or twice daily (PMID 21030672, PMID 32558293, PMID 38980576)
The mechanistic logic NNMT inhibition preserving NAD+ salvage, increasing adipocyte energy expenditure, and protecting against diet-induced adipose accumulation in animal models places 5-Amino-1MQ in a distinct niche compared to the metabolic peptides that dominate the rest of the obesity-research landscape
Research continues to see how BPC-157 and TB-500 have similar effects on tissue models
Fernandez, E
That is important, because it confirms that VEGFR2 is not just one of many mechanisms, but truly a causal pathway